Research article Special Issues

A generalized distributed delay model of COVID-19: An endemic model with immunity waning

  • Received: 30 October 2022 Revised: 13 December 2022 Accepted: 20 December 2022 Published: 12 January 2023
  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide for over two years, with millions of reported cases and deaths. The deployment of mathematical modeling in the fight against COVID-19 has recorded tremendous success. However, most of these models target the epidemic phase of the disease. The development of safe and effective vaccines against SARS-CoV-2 brought hope of safe reopening of schools and businesses and return to pre-COVID normalcy, until mutant strains like the Delta and Omicron variants, which are more infectious, emerged. A few months into the pandemic, reports of the possibility of both vaccine- and infection-induced immunity waning emerged, thereby indicating that COVID-19 may be with us for longer than earlier thought. As a result, to better understand the dynamics of COVID-19, it is essential to study the disease with an endemic model. In this regard, we developed and analyzed an endemic model of COVID-19 that incorporates the waning of both vaccine- and infection-induced immunities using distributed delay equations. Our modeling framework assumes that the waning of both immunities occurs gradually over time at the population level. We derived a nonlinear ODE system from the distributed delay model and showed that the model could exhibit either a forward or backward bifurcation depending on the immunity waning rates. Having a backward bifurcation implies that $ R_c < 1 $ is not sufficient to guarantee disease eradication, and that the immunity waning rates are critical factors in eradicating COVID-19. Our numerical simulations show that vaccinating a high percentage of the population with a safe and moderately effective vaccine could help in eradicating COVID-19.

    Citation: Sarafa A. Iyaniwura, Rabiu Musa, Jude D. Kong. A generalized distributed delay model of COVID-19: An endemic model with immunity waning[J]. Mathematical Biosciences and Engineering, 2023, 20(3): 5379-5412. doi: 10.3934/mbe.2023249

    Related Papers:

  • The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been spreading worldwide for over two years, with millions of reported cases and deaths. The deployment of mathematical modeling in the fight against COVID-19 has recorded tremendous success. However, most of these models target the epidemic phase of the disease. The development of safe and effective vaccines against SARS-CoV-2 brought hope of safe reopening of schools and businesses and return to pre-COVID normalcy, until mutant strains like the Delta and Omicron variants, which are more infectious, emerged. A few months into the pandemic, reports of the possibility of both vaccine- and infection-induced immunity waning emerged, thereby indicating that COVID-19 may be with us for longer than earlier thought. As a result, to better understand the dynamics of COVID-19, it is essential to study the disease with an endemic model. In this regard, we developed and analyzed an endemic model of COVID-19 that incorporates the waning of both vaccine- and infection-induced immunities using distributed delay equations. Our modeling framework assumes that the waning of both immunities occurs gradually over time at the population level. We derived a nonlinear ODE system from the distributed delay model and showed that the model could exhibit either a forward or backward bifurcation depending on the immunity waning rates. Having a backward bifurcation implies that $ R_c < 1 $ is not sufficient to guarantee disease eradication, and that the immunity waning rates are critical factors in eradicating COVID-19. Our numerical simulations show that vaccinating a high percentage of the population with a safe and moderately effective vaccine could help in eradicating COVID-19.



    加载中


    [1] World Health Organization (WHO), WHO's COVID-19 response timeline, 2022. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/interactive-timeline/#category-Information.
    [2] World Health Organization (WHO), WHO Coronavirus (COVID-19) Dashboard, 2022. Available from: https://covid19.who.int/.
    [3] Y. Guo, Q. Cao, Z. Hong, Y. Tan, S. Chen, H. Jin, et al., The origin, transmission and clinical therapies on coronavirus disease 2019 (covid-19) outbreak–an update on the status, Mil. Med. Res., 7 (2020), 1–10. https://doi.org/10.1186/s40779-020-00240-0 doi: 10.1186/s40779-020-00240-0
    [4] R. Karia, I. Gupta, H. Khandait, A. Yadav, A. Yadav, Covid-19 and its modes of transmission, SN Compr. Clin. Med., 2 (2020), 1798–1801. https://doi.org/10.1007/s42399-020-00498-4 doi: 10.1007/s42399-020-00498-4
    [5] S. W. Ong, Y. K. Tan, P. Y. Chia, T. Lee, O. T. Ng, M. S. Wong, et al., Air, surface environmental, and personal protective equipment contamination by severe acute respiratory syndrome coronavirus 2 (sars-cov-2) from a symptomatic patient, Jama, 323 (2020), 1610–1612. https://doi.org/10.1001/jama.2020.3227 doi: 10.1001/jama.2020.3227
    [6] National Center for Immunization, Science brief: Sars-cov-2 and surface (fomite) transmission for indoor community environments, in CDC COVID-19 Science Briefs [Internet], Centers for Disease Control and Prevention (US), 2021.
    [7] World Health Organization (WHO), Scientific Brief: Transmission of SARS-CoV-2: implications for infection prevention precautions, (accessed August 3, 2021). Available from: https://www.who.int/news-room/commentaries/detail/transmission-of-sars-cov-2-implications-for-infection-prevention-precautions#: :text=Transmission.
    [8] S. Mallapaty, Why does the coronavirus spread so easily between people?, Nature, 579 (2020), 183–184.
    [9] Z. Abdelrahman, M. Li, X. Wang, Comparative review of sars-cov-2, sars-cov, mers-cov, and influenza a respiratory viruses, Front. Immunol., (2020), 2309. https://doi.org/10.3389/fimmu.2020.552909
    [10] World Health Organization (WHO), Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV), (accessed June 15, 2021). Available from: https://www.who.int/news/item/.
    [11] World Health Organization (WHO), WHO Director-General's opening remarks at the media briefing on COVID-19. 2020, (accessed June 15, 2021). Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19—11-march-2020.
    [12] N. Lurie, M. Saville, R. Hatchett, J. Halton, Developing covid-19 vaccines at pandemic speed, N. Engl. J. Med., 382 (2020), 1969–1973. https://doi.org/10.1056/NEJMp2005630 doi: 10.1056/NEJMp2005630
    [13] G. Forni, A. Mantovani, Covid-19 vaccines: where we stand and challenges ahead, Cell Death Differ., 28 (2021), 626–639. https://doi.org/10.1038/s41418-020-00720-9 doi: 10.1038/s41418-020-00720-9
    [14] J. K. Jackson, Global economic effects of covid-19, in Technical report, Congressional Research Service, 2021. https://doi.org/10.1016/S2214-109X(21)00289-8
    [15] P. K. Ozili, T. Arun, Spillover of covid-19: impact on the global economy, SSRN Electron. J., 2020. https://doi.org/10.2139/ssrn.3562570
    [16] N. Fernandes, Economic effects of coronavirus outbreak (covid-19) on the world economy, in IESE Business School Working Paper, 2020. https://dx.doi.org/10.2139/ssrn.3557504
    [17] US FDA, Fda takes key action in fight against covid-19 by issuing emergency use authorization for first covid-19 vaccine, 2020. Available from: https://www.fda.gov/news-events/press-announcements/fda-takes-key-action-fight-against-covid-19-issuing-emergency-use-authorization-first-covid-19.
    [18] M. G. Thompson, J. L. Burgess, A. L. Naleway, H. L. Tyner, S. K. Yoon, J. Meece, et al., Interim estimates of vaccine effectiveness of bnt162b2 and mrna-1273 covid-19 vaccines in preventing sars-cov-2 infection among health care personnel, first responders, and other essential and frontline workers—eight us locations, december 2020–march 2021, Morb. Mortal. Wkly. Rep., 70 (2021), 495. https://doi.org/10.15585/mmwr.mm7013e3 doi: 10.15585/mmwr.mm7013e3
    [19] T. Pilishvili, K. E. Fleming-Dutra, J. L. Farrar, R. Gierke, N. M. Mohr, D. A. Talan, et al., Interim estimates of vaccine effectiveness of pfizer-biontech and moderna covid-19 vaccines among health care personnel—33 us sites, january–march 2021, Morb. Mortal. Wkly. Rep., 70 (2021), 753. https://doi.org/10.15585/mmwr.mm7020e2 doi: 10.15585/mmwr.mm7020e2
    [20] W. H. Self, M. W. Tenforde, J. P. Rhoads, M. Gaglani, A. A. Ginde, D. J Douin, et al., Comparative effectiveness of moderna, pfizer-biontech, and janssen (johnson & johnson) vaccines in preventing covid-19 hospitalizations among adults without immunocompromising conditions—united states, march–august 2021, Morb. Mortal. Wkly. Rep., 70 (2021), 1337. https://doi.org/10.15585/mmwr.mm7038e1 doi: 10.15585/mmwr.mm7038e1
    [21] L. Wang, G. Cheng, Sequence analysis of the emerging sars-cov-2 variant omicron in south africa, J. Med. Virol., 94 (2022), 1728–1733. https://doi.org/10.1002/jmv.27516 doi: 10.1002/jmv.27516
    [22] L. T. Brandal, E. MacDonald, L. Veneti, T. Ravlo, H. Lange, U. Naseer, et al., Outbreak caused by the sars-cov-2 omicron variant in norway, november to december 2021, Eurosurveillance, 26 (2021), 2101147. https://doi.org/10.2807/1560-7917.ES.2021.26.50.2101147 doi: 10.2807/1560-7917.ES.2021.26.50.2101147
    [23] R. Antia, M. E. Halloran, Transition to endemicity: Understanding covid-19, Immunity, 54 (2021), 2172–2176. https://doi.org/10.1016/j.immuni.2021.09.019 doi: 10.1016/j.immuni.2021.09.019
    [24] J. S. Lavine, O. N. Bjornstad, R. Antia, Immunological characteristics govern the transition of covid-19 to endemicity, Science, 371 (2021), 741–745. https://doi.org/10.1126/science.abe6522 doi: 10.1126/science.abe6522
    [25] Y. Tang, S. Wang, Mathematic modeling of covid-19 in the united states. Emerging Microbes Infect., 9 (2020), 827–829. https://doi.org/10.1080/22221751.2020.1760146
    [26] A. R. Tuite, D. N. Fisman, A. L. Greer, Mathematical modelling of covid-19 transmission and mitigation strategies in the population of ontario, canada, CMAJ, 192 (2020), E497–E505. https://doi.org/10.1503/cmaj.200476 doi: 10.1503/cmaj.200476
    [27] A. J. Kucharski, T. W. Russell, C. Diamond, Y. Liu, J. Edmunds, S. Funk, et al., Early dynamics of transmission and control of covid-19: a mathematical modelling study, Lancet Infect. Dis., 20 (2020), 553–558. https://doi.org/10.1016/S1473-3099(20)30144-4 doi: 10.1016/S1473-3099(20)30144-4
    [28] S. A. Iyaniwura, R. C. Falcão, N. Ringa, P. A. Adu, M. Spencer, M. Taylor, et al., Mathematical modeling of covid-19 in british columbia: an age-structured model with time-dependent contact rates, Epidemics, (2022), 100559. https://doi.org/10.1016/j.epidem.2022.100559
    [29] F. Ndaïrou, I. Area, J. J. Nieto, D. F. M. Torres, Mathematical modeling of covid-19 transmission dynamics with a case study of wuhan, Chaos Solitons Fractals, 135 (2020), 109846. https://doi.org/10.1016/j.chaos.2020.109846 doi: 10.1016/j.chaos.2020.109846
    [30] D. K. Chu, E. A. Akl, S. Duda, K. Solo, S. Yaacoub, H. J. Schünemann, et al., Physical distancing, face masks, and eye protection to prevent person-to-person transmission of sars-cov-2 and covid-19: a systematic review and meta-analysis, Lancet, 395 (2020), 1973–1987. https://doi.org/10.1016/S0140-6736(20)31142-9 doi: 10.1016/S0140-6736(20)31142-9
    [31] M. A. Khan, Ab. Atangana, E. Alzahrani, Fatmawati, The dynamics of covid-19 with quarantined and isolation, Adv. Differ. Equations, 2020 (2020), 1–22. https://doi.org/10.1186/s13662-020-02882-9 doi: 10.1186/s13662-020-02882-9
    [32] S. C. Anderson, A. M. Edwards, M. Yerlanov, N. Mulberry, J. E. Stockdale, S. A. Iyaniwura, et al., Quantifying the impact of covid-19 control measures using a bayesian model of physical distancing, PLoS Comput. Biol., 16 (2020), e1008274. https://doi.org/10.1371/journal.pcbi.1008274 doi: 10.1371/journal.pcbi.1008274
    [33] S. A. Iyaniwura, M. A. Rabiu, J. David, J. D. Kong, Assessing the impact of adherence to non-pharmaceutical interventions and indirect transmission on the dynamics of covid-19: a mathematical modelling study, medRxiv, 2021. https://doi.org/10.1101/2021.10.23.21265421
    [34] M. Sadarangani, B. A. Raya, J. M. Conway, S. A. Iyaniwura, R. C. Falcao, C. Colijn, et al., Importance of covid-19 vaccine efficacy in older age groups, Vaccine, 39 (2021), 2020–2023. https://doi.org/10.1016/j.vaccine.2021.03.020 doi: 10.1016/j.vaccine.2021.03.020
    [35] N. Mulberry, P. Tupper, E. Kirwin, C. McCabe, C. Colijn, Vaccine rollout strategies: The case for vaccinating essential workers early, PLOS Global Public Health, 1 (2021), e0000020. https://doi.org/10.1371/journal.pgph.0000020 doi: 10.1371/journal.pgph.0000020
    [36] J. Demongeot, Q. Griette, P. Magal, G. Webb, Modeling vaccine efficacy for covid-19 outbreak in new york city, Biology, 11 (2022), 345. https://doi.org/10.3390/biology11030345 doi: 10.3390/biology11030345
    [37] L. M. Pinto, V. Nanda, A. Sunavala, C. Rodriques, Reinfection in covid-19: A scoping review, Med. J. Armed Forces India, 77, S257–S263. https://doi.org/10.1016/j.mjafi.2021.02.010
    [38] S, Roy, Covid-19 reinfection: myth or truth?, SN Compr. Clin. Med., 2 (2020), 710–713. https://doi.org/10.1007/s42399-020-00335-8 doi: 10.1007/s42399-020-00335-8
    [39] D. de A. Torres, L. Ribeiro, A. de F. Riello, D. D. G. Horovitz, L. F. R. Pinto, J. Croda, Reinfection of covid-19 after 3 months with a distinct and more aggressive clinical presentation: Case report, J. Med. Virol., 2020. https://doi.org/10.1002/jmv.26637
    [40] CDC Covid, Vaccine Breakthrough Case Investigations Team, CDC COVID, Vaccine Breakthrough Case Investigations Team, CDC COVID, Vaccine Breakthrough Case Investigations Team, et al., Covid-19 vaccine breakthrough infections reported to cdc—united states, january 1–april 30, 2021, Morb. Mortal. Wkly. Rep., 70 (2021), 792. http://dx.doi.org/10.15585/mmwr.mm7021e3.
    [41] M. Bergwerk, T. Gonen, Y. Lustig, S. Amit, M. Lipsitch, C. Cohen, et al., Covid-19 breakthrough infections in vaccinated health care workers, N. Engl. J. Med., 385 (2021), 1474–1484. http://doi.org/10.1056/NEJMoa2109072 doi: 10.1056/NEJMoa2109072
    [42] R. K. Gupta, E. J. Topol, Covid-19 vaccine breakthrough infections, Science, 374 (2021), 1561–1562. http://doi.org/10.1126/science.abl8487 doi: 10.1126/science.abl8487
    [43] Y. Goldberg, M. Mandel, Y. M. Bar-On, O. Bodenheimer, L. Freedman, E. J. Haas, et al., Waning immunity after the bnt162b2 vaccine in israel, N. Engl. J. Med., 385 (2021), e85. http://doi.org/10.1056/NEJMoa2114228 doi: 10.1056/NEJMoa2114228
    [44] Elie Dolgin, Covid vaccine immunity is waning-how much does that matter, Nature, 597 (2021), 606–607. https://doi.org/10.1038/d41586-021-02532-4 doi: 10.1038/d41586-021-02532-4
    [45] E. G. Levin, Y. Lustig, C. Cohen, R. Fluss, V. Indenbaum, S. Amit, et al., Waning immune humoral response to bnt162b2 covid-19 vaccine over 6 months, N. Engl. J. Med., 385 (2021), e84. https://doi.org/10.1056/NEJMoa2114583 doi: 10.1056/NEJMoa2114583
    [46] E. B. Are, Y. Song, J. E. Stockdale, P. Tupper, C. Colijn, Covid-19 endgame: from pandemic to endemic? vaccination, reopening and evolution in a well-vaccinated population, medRxiv, 2021. https://doi.org/10.1101/2021.12.18.21268002
    [47] A. V. Tkachenko, S. Maslov, T. Wang, A. Elbana, G. N. Wong, N. Goldenfeld, Stochastic social behavior coupled to covid-19 dynamics leads to waves, plateaus, and an endemic state, Elife, 10 (2021), e68341. https://doi.org/10.7554/eLife.68341 doi: 10.7554/eLife.68341
    [48] M. Rabiu, S. A Iyaniwura, Assessing the potential impact of immunity waning on the dynamics of covid-19 in south africa: an endemic model of covid-19, Nonlinear Dyn., (2022), 1–21. https://doi.org/10.1007/s11071-022-07225-9
    [49] N. Nuraini, K. Khairudin, M. Apri, Modeling simulation of covid-19 in indonesia based on early endemic data, Commun. Biomath. Sci., 3 (2020), 1–8.
    [50] W. Zhou, B. Tang, Y. Bai, Y. Shao, Y. Xiao, S. Tang, The resurgence risk of covid-19 in the presence of immunity waning and ade effect: A mathematical modelling study, medRxiv, 2021. https://doi.org/10.1101/2021.08.25.21262601
    [51] F. Inayaturohmat, R. N. Zikkah, A. K. Supriatna, N. Anggriani, Mathematical model of covid-19 transmission in the presence of waning immunity, J. Phys. Conf. Ser., 1722 (2021), 012038. https://doi.org/10.1088/1742-6596/1722/1/012038 doi: 10.1088/1742-6596/1722/1/012038
    [52] T. Xiang, B. Liang, Y. Fang, S. Lu, S. Li, H. Wang, et al., Declining levels of neutralizing antibodies against sars-cov-2 in convalescent covid-19 patients one year post symptom onset, Front. Immunol., 12 (2021), 2327. https://doi.org/10.3389/fimmu.2021.708523 doi: 10.3389/fimmu.2021.708523
    [53] B. Pell, M. D. Johnston, P. Nelson, A data-validated temporary immunity model of covid-19 spread in michigan, Math. Biosci. Eng., 19 (2022), 10122–10142. https://doi.org/10.3934/mbe.2022474 doi: 10.3934/mbe.2022474
    [54] S. Ghosh, M. Banerjee, V. Volpert, Immuno-epidemiological model-based prediction of further covid-19 epidemic outbreaks due to immunity waning, Math. Modell. Nat. Phenom., 17 (2022), 9. https://doi.org/10.1051/mmnp/2022017 doi: 10.1051/mmnp/2022017
    [55] C. P. Tadiri, J. D. Kong, G. F. Fussmann, M. E. Scott, H. Wang, A data-validated host-parasite model for infectious disease outbreaks, Front. Ecol. Evol., (2019), 307. https://doi.org/10.3389/fevo.2019.00307
    [56] Y. Kuang, Delay differential equations: with applications in population dynamics, Academic press, 1993.
    [57] T. Cassidy, Distributed delay differential equation representations of cyclic differential equations, SIAM J. Appl. Math., 81 (2021), 1742–1766. https://doi.org/10.1137/20M1351606 doi: 10.1137/20M1351606
    [58] P. J. Hurtado, A. S. Kirosingh, Generalizations of the 'linear chain trick': incorporating more flexible dwell time distributions into mean field ode models, J. Math. Biol., 79, 1831–1883. https://doi.org/10.1007/s00285-019-01412-w
    [59] H. L. Smith, An introduction to delay differential equations with applications to the life sciences, Springer New York, 2011.
    [60] O. Diekmann, J. A. P. Heesterbeek, J. A. Metz, On the definition and the computation of the basic reproduction ratio r 0 in models for infectious diseases in heterogeneous populations, J. Math. Biol., 28 (1990), 365–382. https://doi.org/10.1007/BF00178324 doi: 10.1007/BF00178324
    [61] P. Van den Driessche, J. Watmough, Reproduction numbers and sub-threshold endemic equilibria for compartmental models of disease transmission, Math. Biosci., 180 (2002), 29–48. https://doi.org/10.1016/S0025-5564(02)00108-6 doi: 10.1016/S0025-5564(02)00108-6
    [62] J. H. Jones, Notes on r0, Calif. Dep. Anthropol. Sci., 323 (2007), 1–19.
    [63] C. Castillo-Chavez, B. Song, Dynamical models of tuberculosis and their applications, Math. Biosci. Eng., 1 (2004), 361. https://doi.org/10.3934/mbe.2004.1.361 doi: 10.3934/mbe.2004.1.361
    [64] M. Rabiu, R. Willie, N. Parumasur, Mathematical analysis of a disease-resistant model with imperfect vaccine, quarantine and treatment, Ric. Mat., 69 (2020), 603–627. https://doi.org/10.1007/s11587-020-00496-7 doi: 10.1007/s11587-020-00496-7
    [65] O. Dyer, Covid-19: Unvaccinated face 11 times risk of death from delta variant, cdc data show, BMJ, 374 (2021). http://dx.doi.org/10.1136/bmj.n2282
    [66] A. Khan, R. Zarin, G. Hussain, N. A. Ahmad, M. H. Mohd, A. Yusuf, Stability analysis and optimal control of covid-19 with convex incidence rate in khyber pakhtunkhawa (pakistan), Results Phys., 20 (2021), 103703. https://doi.org/10.1016/j.rinp.2020.103703 doi: 10.1016/j.rinp.2020.103703
    [67] J. P. La Salle, The stability of dynamical systems, SIAM, 1976.
    [68] U. C. Bureau, Census Bureau Reveals Fastest-Growing Large Cities, (accessed May 27, 2022). Available from: https://www.census.gov/newsroom/press-releases/2018/estimates-cities.html.
    [69] S. Mushayabasa, E. T. Ngarakana-Gwasira, J. Mushanyu, On the role of governmental action and individual reaction on covid-19 dynamics in south africa: A mathematical modelling study, Inf. Med. Unlocked, 20 (2020), 100387. https://doi.org/10.1016/j.imu.2020.100387 doi: 10.1016/j.imu.2020.100387
    [70] Z. Yang, Z. Zeng, K. Wang, S. Wong, W. Liang, M. Zanin, et al., Modified seir and ai prediction of the epidemics trend of covid-19 in china under public health interventions, J. Thorac. Dis., 12 (2020), 165. https://doi.org/10.21037/jtd.2020.02.64 doi: 10.21037/jtd.2020.02.64
    [71] A. Mahajan, R. Solanki, N. Sivadas, Estimation of undetected symptomatic and asymptomatic cases of covid-19 infection and prediction of its spread in the usa, J. Med. Virol., 93 (2021), 3202–3210. https://doi.org/10.1002/jmv.26897 doi: 10.1002/jmv.26897
    [72] S. Choi, M. Ki, Estimating the reproductive number and the outbreak size of covid-19 in korea, Epidemiol. Health, 42, (2020). https://doi.org/10.4178/epih.e2020011
    [73] S. Khajanchi, K. Sarkar, J. Mondal, Dynamics of the covid-19 pandemic in india, preprint, arXiv: 2005.06286.
    [74] L. Zou, F. Ruan, M. Huang, L. Liang, H. Huang, Z. Hong, et al., Sars-cov-2 viral load in upper respiratory specimens of infected patients, N. Engl. J. Med., 382 (2020), 1177–1179. https://doi.org/10.1056/NEJMc2001737 doi: 10.1056/NEJMc2001737
    [75] L. Tindale, M. Coombe, J. E. Stockdale, E. Garlock, W. Y. V. Lau, M. Saraswat, et al., Transmission interval estimates suggest pre-symptomatic spread of covid-19, MedRxiv, 2020. https://doi.org/10.1101/2020.03.03.20029983
    [76] T. Ganyani, C. Kremer, D. Chen, A. Torneri, C. Faes, J. Wallinga, et al., Estimating the generation interval for coronavirus disease (covid-19) based on symptom onset data, march 2020, Eurosurveillance, 25 (2020), 2000257. https://doi.org/10.2807/1560-7917.ES.2020.25.17.2000257 doi: 10.2807/1560-7917.ES.2020.25.17.2000257
    [77] Z. Zhao, X. Li, F. Liu, G. Zhu, C. Ma, L. Wang, Prediction of the covid-19 spread in african countries and implications for prevention and control: A case study in south africa, egypt, algeria, nigeria, senegal and kenya, Sci. Total Environ., 729 (2020), 138959. https://doi.org/10.1016/j.scitotenv.2020.138959 doi: 10.1016/j.scitotenv.2020.138959
    [78] L. Peng, W. Yang, D. Zhang, C. Zhuge, L. Hong, Epidemic analysis of covid-19 in china by dynamical modeling, preprint, arXiv: 2002.06563.
    [79] W. Jassat, C. Mudara, L. Ozougwu, S. Tempia, L. Blumberg, M. Davies, et al., Difference in mortality among individuals admitted to hospital with covid-19 during the first and second waves in south africa: a cohort study, Lancet Global Health, 2021. https://doi.org/10.1016/S2214-109X(21)00289-8
    [80] Webometer, Total Coronavirus Deaths in South Africa, (accessed August 28, 2021). Available from: https://www.worldometers.info/coronavirus/country/south-africa.
    [81] Organisation for Economic Co-operation and Development (OECD) Data, Urban population by city size, (accessed May 27, 2022). Available from: https://data.oecd.org/popregion/urban-population-by-city-size.htm.
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(2076) PDF downloads(172) Cited by(1)

Article outline

Figures and Tables

Figures(6)  /  Tables(3)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog